Since the onset of healthcare reform, the role and power of payers have been growing steadily and has reached a point of painful reality for the industry.
Starting today, companies need to abandon knee-jerk approaches to coping with the burden of proving value to payers, such as tacking on payer messaging efforts to an existing brand strategy. Instead, companies need to start from scratch and incorporate the payer perspective throughout all top-to-bottom…
Meeting Payers’ Value Needs
Future Issues Of Managed Markets
Do you actively pursue collaborations with payers in the development of clinical economic evidence for your:
Optimizing Marketing Using Managed Care Influence
Avoid payer messaging pitfalls
Roshawn Blunt. Market Access and Reimbursement, Eisai Inc., a research-oriented, global pharmaceutical company committed to addressing unmet medical needs. For more information, visit eisai.com/us.
John Doyle, Dr. PH., M.P.H. Managing Director and Practice Leader of Market Access, Quintiles, an integrated bio/pharmaceutical services provider offering clinical, commercial, consulting, and capital solutions. For more information, visit quintiles.com.
Joe Falcon. VP, Managed Markets Practice Leader, TGaS Advisors, a division of KnowledgePoint360, is a provider of benchmark and advisory services for pharmaceutical companies that enable them to evaluate their commercial operations against a confidential industry peer-set. For more information, visit tgas.com.
John Guarino. Senior VP, Managed Markets and Payer Strategy, Palio, an inVentiv company, is a full-service healthcare communications agency. For more information, visit palio.com.
Michelle O’Connor, M.ed., CMR. President, CEO, CMR Institute, a nonprofit, 501(c)3, independent educational organization that provides non-branded, unbiased, and applicable education to pharmaceutical, biotech and medical device and diagnostics professionals. For more information, visit cmrinstitute.org.